Understand FoG in PD: Behavioral Physiology and Clinical Application
Understand Freezing of Gait in Parkinson's Disease: Behavioral Physiology and Clinical Application
1 other identifier
interventional
70
1 country
1
Brief Summary
The overall goals of this proposed study are to investigate the behavioral and neurophysiological mechanisms of patients with Parkinson's disease (PD) experiencing freezing of gait (FoG). More specifically, we aim to determine the behavioral changes in context-dependency and changes in corticomotor excitability associated with FoG.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable parkinson-disease
Started Dec 2016
Typical duration for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 6, 2016
CompletedFirst Posted
Study publicly available on registry
December 8, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedDecember 8, 2016
December 1, 2016
3 years
December 6, 2016
December 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
New Freezing of Gait Questionnaire (NFOG-Q)
The New Freezing of Gait Questionnaire (NFOG-Q) will be used to evaluate the freezing frequency and severity of the patients with PD. It composes of 3 parts; in the first part, a video clip will be shown to the participants with PD and help to classify whether an individual is a freezer or non-freezer. The second and third part of the questionnaire is designed for freezers only. PartⅡassesses the severity of FoG according to the frequency and duration of the freezing episodes, while PartⅢevaluates the impact of freezing on daily activities, such as walking. The reliability and internal consistency of the NFOG-Q have been well-established for patients with PD (Nieuwboer et al., 2009).
30 mins
Context-dependent behavior
A modified finger sequence task is specifically designed to evaluate context-dependent behavior for patients with PD. The participants will be instructed to put their index and middle fingers of both hands on a designated location of an enlarged key-board. The participants will first practice the three sequences for a total of 324 practice trials on the first day. Ten minutes and 24 hours after practice, to control for the medication status, the participants will be tested under the SAME and SWITCH conditions.With these 2 testing conditions, we will be able to calculate a variable called Switch Cost, which is the performance difference between the SWTICH and the SAME conditions normalized by the SAME condition \[100% \* (SWITCH - SAME)/SAME\]. The Switch Cost will be used as an indicator of context-dependency.
40 mins
Secondary Outcomes (9)
The Unified Parkinson's Disease Rating Scale (UPDRS)
30 mins
Montreal Cognitive Assessment (MoCA)
10 mins
The Stroop Color-Word test
5 mins
10-Meter Walk Test (10MWT)
5 mins
The Timed Up and Go (TUG) test
5 mins
- +4 more secondary outcomes
Study Arms (3)
PD+FoG
EXPERIMENTALPD patients with FoG
PD-FoG
ACTIVE COMPARATORPD patients without FoG
Control
ACTIVE COMPARATORage-matched non-disabled adults
Interventions
Participants will receive clinical evaluations, and practice the finger sequence task used to assess context-dependency along with EEG assessment. On the second day, the participants will receive the TMS assessment.
Eligibility Criteria
You may qualify if:
- Individuals with Parkinson's disease
- Healthy control subjects
You may not qualify if:
- unable to follow the instructions
- have other neurological diseases other than PD
- have pacemaker implanted in their body
- have a history of seizure
- have a family history of epilepsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ya-Yun Lee, PHD
National Taiwan University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SCREENING
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 6, 2016
First Posted
December 8, 2016
Study Start
December 1, 2016
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
December 8, 2016
Record last verified: 2016-12